P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

ABSTRACT:

SUBMITTER: Joffe E 

PROVIDER: S-EPMC9430533 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature